Abbvie Inc
LSE:0QCV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbvie Inc
LSE:0QCV
|
US |
|
Manitou BF SA
PAR:MTU
|
FR |
|
Biomarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
B
|
Bitfarms Ltd
TSX:BITF
|
CA |
Wall St Price Targets
0QCV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for 0QCV is 258.96 USD with a low forecast of 190.8 USD and a high forecast of 346.29 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QCV's stock price target?
Price Target
258.96
USD
According to Wall Street analysts, the average 1-year price target for 0QCV is 258.96 USD with a low forecast of 190.8 USD and a high forecast of 346.29 USD.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.
